Oral disopyramide in prophylaxis of arrhythmias following myocardial infarction.
Lancet
; 1(7950): 51-4, 1976 Jan 10.
Article
en En
| MEDLINE
| ID: mdl-54578
ABSTRACT
Oral disopyramide given prophylactically following myocardial infarction has been compared with placebo in a double-blind trial using continuous-tape monoriting of the electocardiogram. It caused a significant reduction in the incidence of ventricular arrhythmias and of the various degrees of heart-block. There was a significant reduction of reinfarction during hospital stay in patients who had received disopyramide. Disopyramide appears to be a safe and effective oral therapy in the prevention of potentially serious arrhythmias following myocardial infarction.
Buscar en Google
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Arritmias Cardíacas
/
Piridinas
/
Disopiramida
/
Infarto del Miocardio
Tipo de estudio:
Clinical_trials
/
Etiology_studies
Límite:
Humans
Idioma:
En
Revista:
Lancet
Año:
1976
Tipo del documento:
Article